<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(22)</volume><submitter>Soylemez S</submitter><pubmed_abstract>The &lt;i>FAM171A2&lt;/i> gene encodes a transmembrane protein that is not well characterized but is implicated in signaling, vesicle trafficking, and interactions with the extracellular matrix. Its specific role in gynecologic malignancies has yet to be defined. To our knowledge, this is the first systematic study to comprehensively assess FAM171A2 expression, clinical relevance, and molecular network interactions in gynecologic malignancies. We employed an integrative approach utilizing multi-platform transcriptomic and proteomic resources-GEPIA2, TNMplot, TIMER2, UALCAN, KM-plotter, Human Protein Atlas (HPA), Gene Expression Omnibus (GEO), STRING, TargetScan, and ENCORI-to comprehensively profile &lt;i>FAM171A2&lt;/i> expression, its clinicopathologic correlations, survival associations, predicted </pubmed_abstract><journal>International journal of molecular sciences</journal><pagination>11126</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12652445</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer.</pubmed_title><pmcid>PMC12652445</pmcid><pubmed_authors>Ayan D</pubmed_authors><pubmed_authors>Soylemez S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer.</name><description>The &lt;i>FAM171A2&lt;/i> gene encodes a transmembrane protein that is not well characterized but is implicated in signaling, vesicle trafficking, and interactions with the extracellular matrix. Its specific role in gynecologic malignancies has yet to be defined. To our knowledge, this is the first systematic study to comprehensively assess FAM171A2 expression, clinical relevance, and molecular network interactions in gynecologic malignancies. We employed an integrative approach utilizing multi-platform transcriptomic and proteomic resources-GEPIA2, TNMplot, TIMER2, UALCAN, KM-plotter, Human Protein Atlas (HPA), Gene Expression Omnibus (GEO), STRING, TargetScan, and ENCORI-to comprehensively profile &lt;i>FAM171A2&lt;/i> expression, its clinicopathologic correlations, survival associations, predicted </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-30T03:28:48.137Z</modification><creation>2026-06-30T03:22:29.785Z</creation></dates><accession>S-EPMC12652445</accession><cross_references><pubmed>41303609</pubmed><doi>10.3390/ijms262211126</doi></cross_references></HashMap>